Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Fusion (1)
- (-) Polymers (3)
- 3-D Printing/Advanced Manufacturing (6)
- Bioenergy (3)
- Buildings (1)
- Chemical Sciences (9)
- Climate Change (3)
- Composites (2)
- Computer Science (2)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (4)
- Environment (3)
- Grid (1)
- Isotopes (4)
- Materials (24)
- Materials Science (17)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (7)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (2)
- Partnerships (3)
- Physics (8)
- Quantum Computing (1)
- Quantum Science (3)
- Renewable Energy (1)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
Rigoberto Advincula, a renowned scientist at ORNL and professor of Chemical and Biomolecular Engineering at the University of Tennessee, has won the Netzsch North American Thermal Analysis Society Fellows Award for 2023.
Chemist Jeff Foster is looking for ways to control sequencing in polymers that could result in designer molecules to benefit a variety of industries, including medicine and energy.
Vera Bocharova at the Department of Energy’s Oak Ridge National Laboratory investigates the structure and dynamics of soft materials—polymer nanocomposites, polymer electrolytes and biological macromolecules—to advance materials and technologies for energy, medicine and other applications.
The materials inside a fusion reactor must withstand one of the most extreme environments in science, with temperatures in the thousands of degrees Celsius and a constant bombardment of neutron radiation and deuterium and tritium, isotopes of hydrogen, from the volatile plasma at th...
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.